JPMorgan Chase & Co. trimmed its position in Dolby Laboratories (NYSE:DLB – Free Report) by 13.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,128 shares of the electronics maker’s stock after selling 26,152 shares during the quarter. JPMorgan Chase & Co. owned 0.18% of Dolby Laboratories worth $12,783,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Entropy Technologies LP grew its stake in shares of Dolby Laboratories by 43.4% in the second quarter. Entropy Technologies LP now owns 17,870 shares of the electronics maker’s stock valued at $1,327,000 after acquiring an additional 5,409 shares in the last quarter. Willis Investment Counsel raised its stake in Dolby Laboratories by 89.9% in the 2nd quarter. Willis Investment Counsel now owns 12,806 shares of the electronics maker’s stock worth $951,000 after purchasing an additional 6,063 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Dolby Laboratories in the 2nd quarter valued at about $1,376,000. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Dolby Laboratories by 18.4% during the 2nd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 14,912 shares of the electronics maker’s stock worth $1,107,000 after purchasing an additional 2,321 shares in the last quarter. Finally, Kingsview Wealth Management LLC acquired a new position in shares of Dolby Laboratories during the 2nd quarter worth approximately $2,214,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on DLB. Tigress Financial lifted their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Robert W. Baird initiated coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price objective on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 1st. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Finally, Rosenblatt Securities decreased their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, November 19th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.
Insider Activity at Dolby Laboratories
In other news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the sale, the senior vice president directly owned 67,435 shares in the company, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP John D. Couling sold 6,164 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $66.12, for a total transaction of $407,563.68. Following the sale, the senior vice president directly owned 115,338 shares in the company, valued at $7,626,148.56. This trade represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 100,363 shares of company stock worth $6,877,014 over the last three months. 38.39% of the stock is owned by insiders.
Dolby Laboratories Price Performance
NYSE DLB opened at $67.06 on Monday. The business has a fifty day moving average price of $67.59 and a two-hundred day moving average price of $71.65. The stock has a market capitalization of $6.40 billion, a PE ratio of 25.50 and a beta of 0.89. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The company had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same quarter last year, the company posted $0.61 EPS. The company’s revenue for the quarter was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, sell-side analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd will be paid a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 2.1%. Dolby Laboratories’s payout ratio is presently 54.75%.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
- Five stocks we like better than Dolby Laboratories
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast
- The Role Economic Reports Play in a Successful Investment Strategy
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- ETF Screener: Uses and Step-by-Step Guide
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
